Total Valuation
Akso Health Group Sponsored ADR has a market cap or net worth of €1.09B. The enterprise value is €105.45M.
Market Cap€1.09B
Enterprise Value€105.45M
Share Statistics
Akso Health Group Sponsored ADR has 854,043,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding854,043,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Akso Health Group Sponsored ADR’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -1.99%.
Return on Equity (ROE)-0.10
Return on Assets (ROA)-0.10
Return on Invested Capital (ROIC)-1.99%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee512.29K
Profits Per Employee-693.19K
Employee Count27
Asset Turnover0.07
Inventory Turnover69.17
Valuation Ratios
The current PE Ratio of Akso Health Group Sponsored ADR is ―. Akso Health Group Sponsored ADR’s PEG ratio is 0.81.
PE Ratio―
PS Ratio119.13
PB Ratio9.11
Price to Fair Value9.11
Price to FCF-8.74
Price to Operating Cash Flow57.43
PEG Ratio0.81
Income Statement
In the last 12 months, Akso Health Group Sponsored ADR had revenue of 13.83M and earned -18.67M in profits. Earnings per share was -0.03.
Revenue13.83M
Gross Profit-11.31K
Operating Income-4.00M
Pretax Income-20.70M
Net Income-18.67M
EBITDA-1.63M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was 6.64M and capital expenditures -87.86M, giving a free cash flow of -81.22M billion.
Operating Cash Flow6.64M
Free Cash Flow-81.22M
Free Cash Flow per Share-0.10
Dividends & Yields
Akso Health Group Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.20
52-Week Price Change-14.89%
50-Day Moving Average1.23
200-Day Moving Average1.36
Relative Strength Index (RSI)46.26
Average Volume (3m)0.00
Important Dates
Akso Health Group Sponsored ADR upcoming earnings date is Dec 5, 2023, Before Open (Confirmed).
Last Earnings DateDec 6, 2022
Next Earnings DateDec 5, 2023
Ex-Dividend Date―
Financial Position
Akso Health Group Sponsored ADR as a current ratio of 21.77, with Debt / Equity ratio of 0.21%
Current Ratio21.77
Quick Ratio21.74
Debt to Market Cap<0.01
Net Debt to EBITDA-0.13
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Akso Health Group Sponsored ADR has paid -1.99M in taxes.
Income Tax-1.99M
Effective Tax Rate0.10
Enterprise Valuation
Akso Health Group Sponsored ADR EV to EBITDA ratio is -1.01K, with an EV/FCF ratio of -8.74.
EV to Sales119.14
EV to EBITDA-1.01K
EV to Free Cash Flow-8.74
EV to Operating Cash Flow-128.84
Balance Sheet
Akso Health Group Sponsored ADR has €11.13M in cash and marketable securities with €63.05K in debt, giving a net cash position of €11.07M billion.
Cash & Marketable Securities€11.13M
Total Debt€63.05K
Net Cash€11.07M
Net Cash Per Share€0.01
Tangible Book Value Per Share€0.25
Margins
Gross margin is 1.00%, with operating margin of -28.92%, and net profit margin of -134.99%.
Gross Margin1.00%
Operating Margin-28.92%
Pretax Margin-149.69%
Net Profit Margin-134.99%
EBITDA Margin-11.77%
EBIT Margin-28.92%
Analyst Forecast
The average price target for Akso Health Group Sponsored ADR is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-13.36%
EPS Growth Forecast95.68%